From: Procalcitonin and mortality in status epilepticus: an observational cohort study
Total cohort | Patients without SE of infectious etiology | |||||
---|---|---|---|---|---|---|
HR | 95 % CI | P value | HR | 95 % CI | P value | |
Death | ||||||
ᅟPCT at SE onset, per μg/L | 1.44 | 1.11 − 1.87 | 0.007 | 1.40 | 1.09 − 1.82 | 0.010 |
ᅟAcute etiology of SE1 | 0.54 | 0.19 − 1.55 | 0.255 | 0.65 | 0.23 − 1.82 | 0.411 |
ᅟInfections during SE | 3.04 | 1.20 − 7.71 | 0.019 | 3.45 | 1.32 − 9.00 | 0.011 |
ᅟCharlson comorbidity index, per unit | 1.35 | 1.09 − 1.67 | 0.005 | 1.27 | 1.02 − 1.57 | 0.030 |
ᅟSTESS, per unit2 | 1.39 | 1.03 − 1.88 | 0.035 | 1.48 | 1.07 − 2.03 | 0.017 |
GOS 1 − 3 | ||||||
ᅟPCT at SE onset, per μg/L | 1.29 | 1.02 − 1.62 | 0.032 | 1.29 | 1.03 − 1.61 | 0.027 |
ᅟAcute etiology of SE1 | 0.59 | 0.34 − 1.03 | 0.062 | 0.68 | 0.38 − 1.22 | 0.196 |
ᅟInfections during SE | 1.67 | 0.98 − 2.85 | 0.059 | 1.68 | 0.97 − 2.94 | 0.066 |
ᅟCharlson comorbidity index, per unit | 1.05 | 0.93 − 1.18 | 0.466 | 1.01 | 0.89 − 1.15 | 0.845 |
ᅟSTESS, per unit2 | 1.04 | 0.89 − 1.22 | 0.628 | 1.06 | 0.90 − 1.24 | 0.498 |